FORM 5 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
|
[ ] Check this box if no longer subject to |
Washington, D.C. 20549 |
OMB Number 3235-0362 |
[ ] Form 3 Holdings Reported |
BENEFICIAL OWNERSHIP |
|
[ ] Form 4 Transactions Reported |
|
|
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
| 1. Name and Address of Reporting Person* Sanders, Elizabeth A. (Last) (First) (Middle) |
4. Statement for Month/Year Fiscal 2000 |
| 12835 Sutter Creek Road (Street) |
5. If Amendment, Date of Original (Month/Year) |
| Sutter Creek, California 95685-9733 (City) (State) (Zip) |
|
| 2. Issuer Name and Ticker or Trading Symbol
Wolverine World Wide, Inc. ("WWW") |
6. Relationship of Reporting Person(s) to Issuer |
| 3. IRS or Social Security Number of Reporting Person (Voluntary) |
7. Individual or Joint/Group
Reporting (check applicable line) X Form Filed by One Reporting Person Form Filed by More than One Reporting Person |
| Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||
| 1. Title of Security (Instr. 3) |
2. Transaction Date (Month/ Day/ Year) |
3. Transaction Code (Instr. 8) |
4. Securities
Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) |
6. Ownership Form: Di- rect (D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr. 4) |
||
| Amount | (A) or (D) | Price | ||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
||||||||
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
| Potential persons who are to respond to the collection of Information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
| Form 5 (continued) | Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
| 1. Title of Derivative
Security (Instr. 3) |
2. Conversion of Exercise Price of Derivative Security |
3. Transaction Date (Month/ Day/ Year) |
4. Transaction Code (Instr. 8) |
5. Number
of Deriva- tive Securities Ac- quired (A) or Dis- posed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
||
| (A) |
(D) |
Date Exercisable |
Expiration Date |
||||
| Stock Option (Right to Buy) | $12.5315 | 4/13/00 | A | 5,187 | 4/13/00 | 4/12/10 | |
| Cash-Only Phantom Stock |
(1)
|
1/1/00 | A | 244.2 | (1) | (1) | |
| Cash-Only Phantom Stock |
(1)
|
2/1/00 | A | 21.2 | (1) | (1) | |
| Cash-Only Phantom Stock |
(1)
|
2/24/00
|
A
|
45.6 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
2/25/00
|
A
|
45.3 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
4/1/00 | A | 230.1 | (1) | (1) | |
| Cash-Only Phantom Stock |
(1)
|
4/12/00 | A | 76.7 | (1) | (1) | |
| Cash-Only Phantom Stock |
(1)
|
4/13/00 | A | 39.9 | (1) | (1) | |
| Cash-Only Phantom Stock |
(1)
|
5/1/00 | A | 20.3 | (1) | (1) | |
| Cash-Only Phantom Stock |
(1)
|
7/1/00
|
A
|
262.5 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
7/10/00
|
A
|
49.2 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
7/11/00
|
A
|
48.5 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
8/1/00
|
A
|
23.9 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
10/1/00
|
A
|
281.9 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
10/2/00
|
A
|
53.7 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
10/3/00
|
A
|
53.5 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
11/1/00
|
A
|
25.1 |
(1)
|
(1)
|
|
| Cash-Only Phantom Stock |
(1)
|
12/13/00
|
A
|
36.6 |
(1)
|
(1)
|
|
|
Cash-Only Phantom Stock |
(1)
|
12/14/00
|
A
|
37.7 |
(1)
|
(1)
|
|
| 7. Title and
Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Deriv- ative Security (Instr. 5) |
9. Number of Deriv- ative Securities Beneficially owned at End of Year (Instr. 4) |
10. Ownership of Derivative Sec- urity: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Bene- ficial Ownership (Instr. 4) |
|
| Title |
Amount
or Number of Shares |
||||
| Common Stock | 5,187 | N/A |
5,187
|
D
|
|
|
|
|
||||
| Common Stock | 244.2 | $10.7505 |
see below
|
D
|
|
| Common Stock | 21.2 | $9.0625 |
see below
|
D
|
|
| Common Stock | 45.6 | $10.9690 |
see below
|
D
|
|
| Common Stock | 45.3 | $11.0315 |
see below
|
D
|
|
| Common Stock | 230.1 | $11.4065 |
see below
|
D
|
|
| Common Stock | 76.7 | $13.0315 |
see below
|
D
|
|
| Common Stock | 39.9 | $12.5315 |
see below
|
D
|
|
| Common Stock | 20.3 | $11.6565 |
see below
|
D
|
|
| Common Stock | 262.5 | $10.00 |
see below
|
D
|
|
| Common Stock | 49.2 | $10.1565 |
see below
|
D
|
|
| Common Stock | 48.5 | $10.3130 |
see below
|
D
|
|
| Common Stock | 23.9 | $10.4688 |
see below
|
D
|
|
| Common Stock | 281.9 | $9.3125 |
see below
|
D
|
|
| Common Stock | 53.7 | $9.3125 |
see below
|
D
|
|
| Common Stock | 53.5 | $9.3440 |
see below
|
D
|
|
| Common Stock | 25.1 | $10.5625 |
see below
|
D
|
|
| Common Stock | 36.6 | $13.6565 |
see below
|
D
|
|
| Common Stock | 37.7 | $13.25 |
7,766.8
|
D
|
|
(1) Award of cash-only phantom stock pursuant to Outside Directors' Deferred Compensation Plan. Cash is payable in either a lump sum or installments after termination of service as a director or upon a change in control of the company. The conversion price at the payment date will be the average of the means of high and low sales prices of common stock on the last day of each month for the 12 months preceding the payment date.
| **Intentional misstatements or omissions of facts constitute | s/Elizabeth A. Sanders | February 13, 2001 | ||
| Federal Criminal Violations. | **Signature of Reporting Person | Date | ||
| See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | Elizabeth A. Sanders By Jeffrey A. Ott Attorney-in-Fact |
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY
The undersigned, a director and/or officer of Wolverine World Wide, Inc., a Delaware corporation (the "Company"), does hereby nominate, constitute and appoint Blake W. Krueger, Stephen L. Gulis, Jr. and Jeffrey A. Ott, or any one or more of them, his or her true and lawful attorneys and agents to do any and all acts and things and to execute and file any and all instruments which such attorneys and agents, or any of them, may deem necessary or advisable to enable the undersigned (in his or her individual capacity or in a fiduciary or other capacity) to comply with the Securities Exchange Act of 1934, as amended (the "Act"), and any requirements of the Securities and Exchange commission in respect thereof, in connection with the preparation, execution and filing of any report or statement of beneficial ownership or changes in beneficial ownership of securities of the Company that the undersigned (in his or her individual capacity or in a fiduciary or other capacity) may be required to file pursuant to Section 16(a) of the Act including, without limitation, full power and authority to sign the undersigned's name, in his or her individual capacity or in a fiduciary or other capacity, to any report or statement on Form 3, 4 or 5, or to any amendments or any successor forms thereto, or any form or forms adopted by the Securities and Exchange Commission in lieu thereof or in addition thereto, hereby ratifying and confirming all that such attorneys and agents, or any of them, shall do or cause to be done by virtue hereof.
The undersigned agrees that the attorneys-in-fact named herein may rely entirely on information furnished orally or in writing by the undersigned to such attorneys-in-fact. The undersigned also agrees to indemnify and hold harmless the Company and the attorneys-in-fact against any losses, claims, damages or liabilities (or actions in respect thereof) that arise out of or are based upon any untrue statement or omission of necessary fact in the information provided by the undersigned to the attorneys-in-fact for purposes of executing, acknowledging, delivering or filing Forms 3, 4, or 5, or any amendments or any successor forms thereto, or any form or forms adopted by the Securities and Exchange Commission in lieu thereof or in addition thereto, and agrees to reimburse the Company and the attorneys-in-fact herein for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.
This authorization shall supersede all prior authorizations to act for the undersigned with respect to securities of the Company in these matters, which prior authorizations are hereby revoked, and shall survive the termination of the undersigned's status as a director and/or officer of the Company and remain in effect thereafter for so long as the undersigned (in his or her individual capacity or in a fiduciary or other capacity) has any obligation under Section 16 of the Act with respect to securities of the Company.
|
Date: October 10, 1994 |
/s/ Elizabeth A. Sanders Elizabeth A. Sanders |